These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 18602994

  • 1. Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles.
    Guo C, Gemeinhart RA.
    Eur J Pharm Biopharm; 2008 Oct; 70(2):597-604. PubMed ID: 18602994
    [Abstract] [Full Text] [Related]

  • 2. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
    Wang M, Zhang Y, Feng J, Gu T, Dong Q, Yang X, Sun Y, Wu Y, Chen Y, Kong W.
    Int J Nanomedicine; 2013 Oct; 8():1141-54. PubMed ID: 23658482
    [Abstract] [Full Text] [Related]

  • 3. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
    Yuan X, Shah BA, Kotadia NK, Li J, Gu H, Wu Z.
    Pharm Res; 2010 Jul; 27(7):1285-95. PubMed ID: 20309616
    [Abstract] [Full Text] [Related]

  • 4. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
    Lee C, Choi JS, Kim I, Oh KT, Lee ES, Park ES, Lee KC, Youn YS.
    Int J Nanomedicine; 2013 Jul; 8():2975-83. PubMed ID: 23976850
    [Abstract] [Full Text] [Related]

  • 5. Iontophoretic transdermal delivery using chitosan-coated PLGA nanoparticles for positively charged drugs.
    Takeuchi I, Takeshita T, Suzuki T, Makino K.
    Colloids Surf B Biointerfaces; 2017 Dec 01; 160():520-526. PubMed ID: 29017147
    [Abstract] [Full Text] [Related]

  • 6. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
    Guan XP, Quan DP, Liao KR, Tao Wang, Peng Xiang, Mai KC.
    J Biomater Appl; 2008 Jan 01; 22(4):353-71. PubMed ID: 17494965
    [Abstract] [Full Text] [Related]

  • 7. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S, Koli U, Dharamdasani V, Jain R, Dandekar P.
    Drug Deliv Transl Res; 2016 Aug 01; 6(4):365-79. PubMed ID: 27106502
    [Abstract] [Full Text] [Related]

  • 8. Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine.
    Grabovac V, Bernkop-Schnürch A.
    Drug Dev Ind Pharm; 2007 Jul 01; 33(7):767-74. PubMed ID: 17654025
    [Abstract] [Full Text] [Related]

  • 9. Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
    Ravi Kumar MN, Bakowsky U, Lehr CM.
    Biomaterials; 2004 May 01; 25(10):1771-7. PubMed ID: 14738840
    [Abstract] [Full Text] [Related]

  • 10. Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery.
    Wang Y, Li P, Kong L.
    AAPS PharmSciTech; 2013 Jun 01; 14(2):585-92. PubMed ID: 23463262
    [Abstract] [Full Text] [Related]

  • 11. Comparative studies on chitosan and polylactic-co-glycolic acid incorporated nanoparticles of low molecular weight heparin.
    Yang T, Nyiawung D, Silber A, Hao J, Lai L, Bai S.
    AAPS PharmSciTech; 2012 Dec 01; 13(4):1309-18. PubMed ID: 23054983
    [Abstract] [Full Text] [Related]

  • 12. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
    Gargouri M, Sapin A, Arıca-Yegin B, Merlin JL, Becuwe P, Maincent P.
    Int J Pharm; 2011 Jan 17; 403(1-2):276-84. PubMed ID: 21044878
    [Abstract] [Full Text] [Related]

  • 13. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N, Jackson TL, Elsaid Z, Alqathama A, Somavarapu S.
    Mol Pharm; 2016 Sep 06; 13(9):2923-40. PubMed ID: 27286558
    [Abstract] [Full Text] [Related]

  • 14. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P, Xu Y, Zeng C, Ren H, Peng M.
    Int J Pharm; 2011 Aug 30; 415(1-2):259-66. PubMed ID: 21645597
    [Abstract] [Full Text] [Related]

  • 15. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles using sodium carboxymethyl cellulose as colloidal stabilize.
    Chittasupho C, Thongnopkoon T, Kewsuwan P.
    Curr Drug Deliv; 2016 Aug 30; 13(1):95-104. PubMed ID: 26338259
    [Abstract] [Full Text] [Related]

  • 16. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
    Ignjatović NL, Penov-Gaši KM, Wu VM, Ajduković JJ, Kojić VV, Vasiljević-Radović D, Kuzmanović M, Uskoković V, Uskoković DP.
    Colloids Surf B Biointerfaces; 2016 Dec 01; 148():629-639. PubMed ID: 27694053
    [Abstract] [Full Text] [Related]

  • 17. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
    Salama AH, Mahmoud AA, Kamel R.
    AAPS PharmSciTech; 2016 Oct 01; 17(5):1159-72. PubMed ID: 26589410
    [Abstract] [Full Text] [Related]

  • 18. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles.
    Lee C, Seo J, Hwang HS, Thao LQ, Lee S, Lee ES, Lee EH, Choi HG, Youn YS.
    Biomed Pharmacother; 2016 Mar 01; 78():226-233. PubMed ID: 26898446
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic efficacy of rebamipide-loaded PLGA nanoparticles coated with chitosan in a mouse model for oral mucositis induced by cancer chemotherapy.
    Takeuchi I, Kamiki Y, Makino K.
    Colloids Surf B Biointerfaces; 2018 Jul 01; 167():468-473. PubMed ID: 29723818
    [Abstract] [Full Text] [Related]

  • 20. The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles.
    Kim BS, Kim CS, Lee KM.
    Arch Pharm Res; 2008 Aug 01; 31(8):1050-4. PubMed ID: 18787796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.